Aprima, a physician pratice-focused EHR provider has announced an integration partnership with Genomic Decision Support platform ActX to bring precision medicine into the physician’s office. The addition of the ActX platform provides Aprima clients with access to genomics in everyday patient care and delivers clinically actionable insights that facilitate personalized medication and screening choices based on a patient’s unique genetic profile.
Imagine, during your office visit, your physician writes a prescription for you on their computer. An alert pops up showing that a medication is likely not to work for you because of your genetics. Your physician prescribes a different medication. 87% of people have genetic variants that affect medications, bringing extensive implications to reducing adverse medication reactions.
The integration of ActX real-time genomic decision support into the Aprima EHR means providers will get drug genomic interaction alerts as part of their normal prescription workflow, informing them of possible issues regarding medication efficacy, adverse reactions or dosing. The combined solution gives providers critical patient information to help them personalize therapies and manage actionable hereditary risks, lowering the potential adverse medication reactions. The ActX and Aprima integrated solution makes genomics practical for physicians, ushering in a new era of precision medicine.
“Personalized medicine, including the incorporation of genetics into everyday care, is an exciting development for healthcare and holds great promise for improving patient health outcomes,” said Michael Nissenbaum, Aprima CEO and president. “ActX is highly regarded in the industry and known for delivering comprehensive testing services and providing quality integration. We believe this is the ideal partner for helping us make this cutting-edge technology readily available to our customers.”
The ActX Genomic Decision Support platform will be available through the Aprima EHR beginning in late summer 2017.
